Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Vital Signs Monitoring Devices Market Size & Growth Forecast 2027–2036, By Segments (Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 6674| Published Date: Sep-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Vital Signs Monitoring Devices Market size stood at USD 11.5 billion in 2026 and is predicted to grow at a 7.32% CAGR from 2027 to 2036, exceeding USD 23.31 billion by 2036. The industry revenue for 2027 is estimated at USD 12.21 billion.

Base Year Value (2026)
USD 11.5 billion
CAGR (2027-2036)
7.32%
Forecast Year Value (2036)
USD 23.31 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Vital Signs Monitoring Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 43.78% market share in 2026, supported by widespread deployment across hospitals, ambulatory care, and home settings, along with strong demand for connected monitoring systems.
  • Asia Pacific is expected to grow at a 10.85% CAGR, driven by expanding healthcare access, wider use of portable and remote monitoring, and increasing demand for chronic disease management.

Segment Momentum

  • Blood Pressure Monitors remain the leading product because they are routinely used across hospitals, outpatient care, and home settings for convenient, repeatable monitoring and long-term health tracking.
  • Homecare Settings are growing fastest as patients and caregivers increasingly prefer convenient, ongoing vital sign monitoring outside hospitals, supporting flexible long-term observation without frequent facility visits.

Market Expansion Drivers

  • Rising home healthcare adoption increasing demand for wearable and remote monitoring devices.
  • Growing prevalence of chronic diseases accelerating continuous vital signs monitoring deployment.
  • Expansion of telehealth and predictive analytics enhancing connected patient monitoring ecosystems.

Leading Market Participants

  • Leading players in the vital signs monitoring devices market include Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), GE HealthCare Technologies Inc. (United States), Nihon Kohden Corporation (Japan), Masimo Corporation (United States), Omron Healthcare Co., Ltd. (Japan), Nonin Medical, Inc. (United States), Halma plc (SunTech Medical, Inc.) (United States), CONTEC Medical Systems Co., Ltd. (China), A&D Company, Limited (Japan).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 11.5 billion
  • 2027 Estimated Market Size: USD 12.21 billion.
  • Projected Market Size: USD 23.31 billion by 2036
  • Growth Forecast: 7.32% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Blood Pressure Monitors (Product) | Hospitals (End-use)
  • Emerging Opportunity Segment: Blood Pressure Monitors (Product) | Homecare Settings (End-use)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising home healthcare adoption increasing demand for wearable and remote monitoring devices

Rising adoption of home healthcare will drive the vital signs monitoring devices market growth as patients increasingly receive routine monitoring outside traditional clinical settings. Wearable and portable devices can track parameters such as heart rate, blood pressure, oxygen saturation, and temperature while allowing healthcare professionals to access relevant information remotely. This approach can reduce the need for frequent facility visits and support ongoing observation of patients who require regular assessment during recovery, long-term care, or routine health management.

Growing prevalence of chronic diseases accelerating continuous vital signs monitoring deployment

The vital signs monitoring devices market is benefiting from the growing prevalence of chronic conditions that require regular observation of physiological parameters. Continuous or repeated monitoring can help healthcare providers identify changes in a patient's condition and support timely intervention when measurements move outside expected ranges. As chronic disease management increasingly emphasizes ongoing patient engagement and preventive care, demand is expanding for devices that can collect reliable measurements in hospitals, outpatient settings, and homes.

Expansion of telehealth and predictive analytics enhancing connected patient monitoring ecosystems

Expansion of telehealth services will propel the vital signs monitoring devices market as connected monitoring technologies become increasingly integrated with remote clinical care. Devices capable of transmitting physiological data to digital healthcare platforms allow clinicians to review patient measurements without requiring every assessment to occur in person. Predictive analytics can further evaluate changes across collected data and help identify potential deterioration or emerging health risks, strengthening coordination between connected monitoring devices, telehealth platforms, and clinical decision-making workflows.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising home healthcare adoption increasing demand for wearable and remote monitoring devices 2.00% Moderate North America, Asia Pacific High Near Term
Growing prevalence of chronic diseases accelerating continuous vital signs monitoring deployment 1.80% Moderate North America, Europe High Mid Term
Expansion of telehealth and predictive analytics enhancing connected patient monitoring ecosystems 1.50% High Asia Pacific, North America Emerging Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Vital Signs Monitoring Devices Market
Largest Region
North America
43.78% Market Share in 2026

North America (Largest Region)

North America held the largest share of the vital signs monitoring devices market, with a 43.78% share in 2026. The region benefits from well-established healthcare infrastructure, strong adoption of advanced medical technologies, and increasing emphasis on continuous patient monitoring. Hospitals and other healthcare facilities are increasingly incorporating connected and automated monitoring devices to support timely clinical decision-making, improve patient observation, and streamline care delivery. Demand is also supported by the growing prevalence of chronic conditions, an aging population, and the expansion of home-based and remote care models. Technological advancements in wearable and connected monitoring solutions, together with greater healthcare digitization, are further strengthening the adoption of vital signs monitoring devices across both clinical and non-clinical care settings.

Asia Pacific (Fastest-Growing Region)

In Asia Pacific, rapid healthcare infrastructure development and expanding access to medical technologies are supporting the fastest growth of the market. Increasing healthcare expenditure, growing patient populations, and the modernization of hospitals are encouraging greater use of reliable monitoring equipment across diverse healthcare environments. The expansion of remote healthcare and digital health services is also creating demand for portable and connected monitoring solutions that can support care beyond traditional hospital settings. In addition, rising awareness of preventive healthcare and improvements in healthcare delivery infrastructure are encouraging providers to adopt technologies that enable more efficient and continuous assessment of patient conditions.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Clinical Precision Focus

Germany emphasizes high-accuracy vital signs monitoring devices that support intensive care, surgical environments, and digital hospital initiatives. Procurement decisions increasingly favor reliable performance, regulatory compliance, and seamless integration with clinical infrastructure.

France 🇫🇷

Hospital Modernization Support

France invests in vital signs monitoring devices that strengthen hospital modernization and outpatient care delivery. Healthcare providers prioritize dependable monitoring platforms that improve patient safety while supporting efficient resource utilization across healthcare networks.

Italy 🇮🇹

Critical Care Enhancement

Italy focuses on upgrading vital signs monitoring devices for emergency departments, intensive care units, and post-acute care facilities. Hospitals increasingly seek flexible monitoring solutions that enhance patient surveillance while supporting efficient clinical workflows.

Japan 🇯🇵

Aging Care Integration

Japan expands the use of vital signs monitoring devices to support elderly care, chronic disease management, and hospital automation. Healthcare providers increasingly adopt compact, dependable systems that enable continuous patient observation while easing workforce constraints.

South Korea 🇰🇷

Smart Hospital Deployment

South Korea advances vital signs monitoring devices through smart hospital programs and digitally connected healthcare facilities. Local demand favors AI-enabled monitoring capabilities, wireless connectivity, and rapid data exchange that improve clinical decision-making.

United States 🇺🇸

Connected Care Adoption

The U.S. prioritizes vital signs monitoring devices that integrate with hospital information systems and remote patient monitoring platforms. Demand is centered on continuous monitoring, interoperability, and workflow efficiency across acute care and home healthcare settings.

Segment Analysis

Segment Leadership and Growth Trends

Vital Signs Monitoring Devices Market Share (%), by Product, 2026

Blood Pressure Monitors
Pulse Oximeters
Temperature Monitors
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Segment Analysis: Blood Pressure Monitors (Largest & Fastest-Growing Segment)

The blood pressure monitors segment accounted for the largest share in the vital signs monitoring devices market in 2026 and is also positioned as the fastest-growing segment. Its strong position is supported by the widespread need to monitor hypertension and cardiovascular health across clinical and home-based settings, where blood pressure measurement remains a routine component of patient assessment. Increasing emphasis on preventive healthcare, regular health monitoring, and early identification of abnormal readings continues to sustain demand. The growing availability of easy-to-use digital monitoring devices is also encouraging more frequent measurements outside traditional clinical environments, reinforcing the segment's role across the broader vital signs monitoring landscape.

End-use Segment Analysis: Hospitals (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)

Hospitals held the largest share of the vital signs monitoring devices market in 2026, supported by the essential role of continuous and routine vital-sign assessment in patient diagnosis, treatment, and recovery. Hospital environments require dependable monitoring equipment across emergency care, intensive care, surgery, and general wards, creating consistent demand for devices that support timely clinical decisions. The increasing focus on patient safety and efficient care delivery further strengthens the adoption of vital signs monitoring technologies within healthcare facilities.

Homecare settings are emerging as the fastest-growing end-use segment as healthcare delivery increasingly extends beyond hospitals. Growing preference for remote patient monitoring, chronic disease management, and convenient at-home care is encouraging the use of compact and user-friendly monitoring devices. This shift can help patients and caregivers track health conditions more regularly while supporting healthcare providers in maintaining oversight without requiring every measurement to take place in a clinical environment.

Segment Sub-Segment Largest Segment Fastest Growing
Product Blood Pressure Monitors, Pulse Oximeters, Temperature Monitors, Others Blood Pressure Monitors Blood Pressure Monitors
End-use Hospitals, Homecare Settings, Ambulatory Surgical Centers, Others Hospitals Homecare Settings
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the vital signs monitoring devices market:

1. Koninklijke Philips N.V. (Netherlands)

2. Medtronic plc (Ireland)

3. GE HealthCare Technologies Inc. (United States)

4. Nihon Kohden Corporation (Japan)

5. Masimo Corporation (United States)

6. Omron Healthcare Co. Ltd. (Japan)

7. Nonin Medical Inc. (United States)

8. Halma plc (SunTech Medical Inc.) (United States)

9. CONTEC Medical Systems Co. Ltd. (China)

10. A&D Company Limited (Japan)

The vital signs monitoring devices market is evolving through advancements in real-time patient monitoring technologies. Increasing adoption of wearable health devices is improving continuous care capabilities. Continuous innovation in sensor-based systems is enhancing diagnostic accuracy, while integration into healthcare networks is strengthening remote monitoring efficiency.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Koninklijke Philips N.V. (Netherlands)
Medtronic plc (Ireland)
GE HealthCare Technologies Inc. (United States)
Nihon Kohden Corporation (Japan)
Masimo Corporation (United States)
Omron Healthcare Co. Ltd. (Japan)
Nonin Medical Inc. (United States)
Halma plc (SunTech Medical Inc.) (United States)
CONTEC Medical Systems Co. Ltd. (China)
A&D Company Limited (Japan).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Cardinal Health Jun-25 Cardinal Health launched the Kendall DL™ Multi System, a single-patient use cable and lead wire solution. This device enables continuous monitoring of cardiac activity, blood oxygen levels, and temperature through a single connection point, streamlining clinical workflows and reducing the risk of cross-contamination associated with reusable lead wires in high-acuity hospital settings.
Zynex May-25 Zynex, Inc. submitted a 510(k) application to the U.S. FDA for its NiCO™ non-invasive laser CO-oximeter. This laser-based technology aims to improve pulse oximetry accuracy across diverse patient skin pigments by measuring all four primary hemoglobin species, potentially setting a new standard for reliable real-time oxygenation status monitoring in hospital and non-hospital care environments.
BioIntelliSense Feb-25 BioIntelliSense partnered with Hicuity Health to provide an end-to-end continuous patient monitoring solution. By integrating the BioButton® multi-parameter wearable and BioDashboard™ clinical intelligence system with Hicuity’s 24/7 virtual nursing services, the partnership enables health systems to scale remote monitoring from hospital wards to home-care settings while mitigating clinical staffing shortages.
GE Healthcare Apr-24 GE Healthcare received U.S. FDA approval for its Portrait VSM, a vital signs monitor designed to enhance clinical decision-making. The device facilitates rapid, accurate, and automated spot-check measurements, allowing clinicians to view a comprehensive dashboard of a patient’s condition, thereby improving the efficiency of routine patient assessments and reducing documentation time in hospital environments.
Masimo Corporation Jun-23 Masimo received FDA approval for its Radius VSM, a patient-worn, continuous multi-parameter vital signs monitor. The device enables the integration of Masimo SET® pulse oximetry, noninvasive blood pressure, temperature, respiration rate, and ECG monitoring into a single wearable form factor, facilitating flexible, high-acuity monitoring without tethering patients to bedside monitors.
Medtronic Aug-22 Medtronic established an exclusive U.S. distribution partnership with BioIntelliSense to offer the BioButton® multi-parameter wearable for continuous patient monitoring. This collaboration expanded Medtronic’s patient monitoring division into the remote and post-acute care segment, enabling hospitals to extend clinical oversight beyond the hospital stay to high-risk patients during the 30-day post-discharge recovery period.
Hillrom Jun-20 Hillrom launched its Extended Care Solution, a connected remote monitoring device designed to support the transition of care from hospital settings to the home. By utilizing wearable sensing technology to track vital signs, the system allows clinicians to proactively identify physiological deterioration in chronic care patients, effectively shifting the site of care to lower-cost, home-based environments.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Vital Signs Monitoring Devices Market — Custom Segments

Segment Sub-Segment
Connectivity Wired, Wireless, Bluetooth-Enabled, Wi-Fi-Enabled, Cellular-Enabled
Monitoring Method Intermittent Monitoring, Continuous Monitoring, Spot-Check Monitoring, Remote Monitoring
Patient Acuity Critical Care, Acute Care, Post-Acute Care, Low-Acuity Care

Vital Signs Monitoring Devices Market — Custom TOC

Custom Chapter Custom Details
Remote Patient Monitoring Adoption Strategies
  • Remote Monitoring Adoption Across Care Settings
  • Patient and Provider Use-Case Evolution
  • Technology and Connectivity Enablers
  • Adoption Barriers and Deployment Priorities
  • Strategic Pathways for Remote Monitoring Expansion
Hospital Workflow Integration Opportunities
  • Integration of Vital Signs Monitoring into Clinical Workflows
  • Interoperability and Health Information System Connectivity
  • Workflow Automation and Clinical Decision Support
  • Deployment Priorities Across Hospital Care Environments
AI-Enabled Vital Signs Analytics Trends
  • AI-Driven Monitoring and Clinical Analytics Applications
  • Predictive Insights and Early-Detection Use Cases
  • Intelligent Alerting and Workflow Optimization
  • Data Infrastructure and Analytics Adoption Requirements

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the market valuation of vital signs monitoring devices?

The market size of the vital signs monitoring devices is estimated at USD 12.21 billion in 2027.

What is the projected value of the vital signs monitoring devices industry by 2036?

Vital Signs Monitoring Devices Market size stood at USD 11.5 billion in 2026 and is predicted to grow at a 7.32% CAGR from 2027 to 2036, exceeding USD 23.31 billion by 2036.

How is the shift toward home healthcare affecting demand for vital signs monitoring devices?

Home healthcare expansion is increasing demand for wearable, easy-to-use monitoring devices with remote connectivity, enabling continuous patient tracking outside hospitals and shifting purchasing toward patient-friendly, digitally connected systems.

How are chronic diseases influencing long-term adoption of continuous monitoring solutions?

Rising chronic disease prevalence is driving demand for continuous multi-parameter monitoring, supporting long-term patient management models that rely on real-time physiological data for early intervention and treatment adjustment.

Why do Blood Pressure Monitors lead the vital signs monitoring devices market?

Blood Pressure Monitors remain the leading product because they are routinely used across hospitals, outpatient care, and home settings for convenient, repeatable monitoring and long-term health tracking.

Why are Homecare Settings the fastest-growing end-use segment in the vital signs monitoring devices market?

Homecare Settings are growing fastest as patients and caregivers increasingly prefer convenient, ongoing vital sign monitoring outside hospitals, supporting flexible long-term observation without frequent facility visits.

Why does North America dominate the vital signs monitoring devices market?

North America held a 43.78% market share in 2026, supported by widespread deployment across hospitals, ambulatory care, and home settings, along with strong demand for connected monitoring systems.

What is driving growth in the vital signs monitoring devices market in Asia Pacific?

Asia Pacific is expected to grow at a 10.85% CAGR, driven by expanding healthcare access, wider use of portable and remote monitoring, and increasing demand for chronic disease management.

Which companies dominate the vital signs monitoring devices landscape?

Leading players in the vital signs monitoring devices market include Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), GE HealthCare Technologies Inc. (United States), Nihon Kohden Corporation (Japan), Masimo Corporation (United States), Omron Healthcare Co., Ltd. (Japan), Nonin Medical, Inc. (United States), Halma plc (SunTech Medical, Inc.) (United States), CONTEC Medical Systems Co., Ltd. (China), A&D Company, Limited (Japan).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →